TP53 and acute myeloid leukemia: Expression of p53 or p19Arf protein in the absence of an apoptotic stimulus is indicative of mutation or loss of p53 respectively.44 However, none of 27 AMLs tested expressed detectable levels of either of these proteins (Figure 2a), suggesting that mutations affecting the p53 pathway were rare, as is also the situation in human AML.2